Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hinge Health (HNGE) Gains from Investment Securities (2024 - 2025)

Hinge Health's Gains from Investment Securities history spans 2 years, with the latest figure at -$272.3 million for Q4 2025.

  • For Q4 2025, Gains from Investment Securities fell 1815160.0% year-over-year to -$272.3 million; the TTM value through Dec 2025 reached -$203000.0, changed N/A, while the annual FY2025 figure was -$1000.0, 100.05% down from the prior year.
  • Gains from Investment Securities for Q4 2025 was -$272.3 million at Hinge Health, down from $272.1 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $272.1 million in Q3 2025 and bottomed at -$272.3 million in Q4 2025.